首页 | 本学科首页   官方微博 | 高级检索  
     

抗感染组织工程化骨的生物特性
引用本文:毕龙,胡蕴玉,徐修礼,李丹. 抗感染组织工程化骨的生物特性[J]. 中国组织工程研究与临床康复, 2003, 7(17): 2429-2431
作者姓名:毕龙  胡蕴玉  徐修礼  李丹
作者单位:1. 解放军第四军医大学西京医院全军骨科研究所,陕西省西安市,710032
2. 解放军第四军医大学西京医院检验科,陕西省西安市,710032
基金项目:军队“九五”指令性课题基金资助(962052)~~
摘    要:
目的探索抗感染组织工程化骨一期修复感染性骨折、骨缺损的新途径。方法昆明小鼠84只,雄性,体重24~27g。其中30只于右侧股部肌袋植入利福平组织工程化骨做药物释放特性观察。54只以随机数字法分为A,B,C3组,每组18只。将植骨材料植入小鼠右侧股部肌袋中。A组植入利福平组织工程化骨,B组植入单纯组织工程化骨,C组植入牛松质骨,做成骨活性观察。结果①此种材料21d内骨粒周围软组织的利福平浓度(1.8mg/L)高于金黄色葡萄球菌的最小抑菌浓度(0.008~0.06mg/L),而小鼠血药浓度很低。②此种材料的成骨活性与单纯组织工程化骨无明显差别(P>0.05),均较单纯牛松质骨载体的成骨活性好(P<0.01)。碱性磷酸酶(μmol/s·kg)测定显示:7dA组43±12,B组48±10,C组22±5,F=7.56,P<0.01;14dA组65.3±3.2,B组63.0±2.8,C组18.2±2.7,F=34.86,P<0.01;28dA组122±20,B组133±12,C组27±7,F=53.86,P<0.01。结论一定剂量的利福平组织工程化骨有较好的成骨活性和极好的抗感染能力,且能保持很低的血药浓度。

关 键 词:生物相容性材料  利福平  骨代用品  成骨细胞

Bioactivity of anti- infectious tissue- engineered bone
Long Bi,Yun Yu Hu,Xiu Li Xu,Dan Li

Long Bi,Yun Yu Hu,Dan Li. Bioactivity of anti- infectious tissue- engineered bone[J]. Journal of Clinical Rehabilitative Tissue Engineering Research, 2003, 7(17): 2429-2431

Authors:Long Bi  Yun Yu Hu  Xiu Li Xu  Dan Li

Long Bi  Yun Yu Hu  Dan Li

Affiliation:Long Bi,Yun Yu Hu,Xiu Li Xu,Dan Li

Long Bi,Yun Yu Hu,Dan Li,Institute of Orthopaedics,Xijing Hospital,The Fourth Military Medical University,Xi'an 710032,Shaanxi Province,China

Xiu Li Xu,Department of Laboratory,The Fourth Military Medical University,Xi'an 710032,Shaanxi Province,China

Abstract:
Aim To explore new way of anti- infectious tissue- engineered bone during primary recovery in treating infectious fracture and bony defects. Methods Eighty- four male Kunming mice weighted from 24 to 27 g were prepared.The muscle bags inside right thigh of thirty mice were implanted rifampin tissue- engineered bone for observing characteristics of drug release in vivo.Another fifty- four mice were divided randomly into A,B and C group according to random number method(eighteen mice in each group).The mice in A group were implanted with rifampin tissue- engineered bone,those in B group were implanted with simple tissue- engineered bone and those in C group were implanted with bovine spongy bone.Then the osteoinductive ability of those were observed.Results ① The rifampin concentration(1.8 mg/L) in surrounding soft tissue of bone granulation was higher than minimal isorrheic concentration(MIC) of staphylococcus aureus(0.008 to 0.06 mg/L) within 21 days after using this material and the blood drug concentration of mice was lower.② There was no significant difference in the osteoproductive ability between this material and simple tissue- engineered bone(P >0.05).Which all had better effects than that of simple bovine spongy carrier(P< 0.001).Measurement of alkaline phosphatease(μ mol/s@ kg) showed that it was 43± 12 in A group, 48± 10 in B group and 22± 5 in C group(F=7.56,P< 0.01) on 7th day and 65.3± 3.2 in A group, 63.0± 2.8 in B group and 18.2± 2.7 in C group(F=34.86,P< 0.01) on 14th day,and 122± 20 in A group, 133± 12 in B group and 27± 7 in C group(F=53.86,P< 0.01) on 28th day.Conclusion Anti- infectious tissue- engineered bone with some dose has high osteoinductive ability and anti- infectious activity with little blood drug concentration.
Keywords:biocompatilbe materials  rifampin  bone substitubes  osteoblasts  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号